Ayşegül A. Şahin

Supplementary Table 2 from Low–Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer

Mi Li, Amriti R. Lulla, Yan Wang, Spyros Tsavachidis et autres

Supplementary Table 1 from Low–Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer

Mi Li, Amriti R. Lulla, Yan Wang, Spyros Tsavachidis et autres

World Health Organization classification of tumours of the breast 6th edition 2026

Cecily Quinn, Puay Hoon Tan, Kimberly H. Allison, Edi Brogi et autres

ie, sg, us, au, be, it, Ghana, at, in, cz, hk, fr, gb (code pays fourni par la source)

144 Impact of ARID1A Mutations and GATA3 Mutations in Metastatic ER-positive/HER2-negative Breast Carcinoma

Xiao Huang, Kanako Okamoto, Shuko Harada, Richard K. Yang et autres

us (code pays fourni par la source)

Advances in Targeting HER2 across Cancer Subtypes: A Pan-Tumor Approach

Taiwo Adesoye, Ecaterina E. Dumbrava, Kanwal Raghav, Ayşegül A. Şahin et autres

us (code pays fourni par la source)

Supplemental Figures and Figure Legends from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers

Juliana Navarro-Yepes, Nicole M. Kettner, Xiayu Rao, Cassandra Santaella Bishop et autres

Supplementary Materials and Methods from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers

Juliana Navarro-Yepes, Nicole M. Kettner, Xiayu Rao, Cassandra Santaella Bishop et autres

Supplementary Table 1 from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers

Juliana Navarro-Yepes, Nicole M. Kettner, Xiayu Rao, Cassandra Santaella Bishop et autres

TRPS1 expression in neuroendocrine neoplasms of breast and other organs

Qiqi Ye, Jeannelyn S. Estrella, Neda Kalhor, Audrey Liu et autres

us (code pays fourni par la source)

Association between p16INK4A expression and a treatment response to CDK4/6 inhibitor in advanced breast carcinoma

Xiao Huang, Shuko Harada, Shi W, Gene P. Siegal et autres

us (code pays fourni par la source)

Emerging molecular Therapeutic targets in breast Cancer: Pathologic identification and clinical implications

Ayşegül A. Şahin, Hui Chen, Damodaran Senthil, Funda Meric‐Bernstam

us (code pays fourni par la source)

IL-6 predicts CDK4/6 inhibitor resistance, identifying STAT3 as a target in HR + /HER2-negative metastatic breast cancer

Nicole M. Kettner, Tuyen Bui, Juliana Navarro-Yepes, Sanaz Ghotbaldini et autres

us (code pays fourni par la source)